![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Institute of Cancer Research, Columbia University, New York, New York 10032.
Abstract
Exposure of rat thyroid cells for 1 week to a temperature-sensitive variant of Kirsten murine sarcoma virus (KiMSV) Ras inactivated the thyroglobulin promoter (pTg). Cellular dedifferentiation was paralleled by the loss of the thyroid-specific trans-acting factor, TgTF1, which binds to pTg. When Ras was denatured by shifting cells to 39 degrees C, TgTF1 binding and pTg function recovered rapidly without the synthesis of new protein. TgTF1 could be reactivated in vitro by treating nuclear extracts with protein kinase A. After 4 weeks of exposure to the oncogene, denaturation of Ras no longer restored TgTF1 binding or reactivated pTg. Incubation of nuclear extracts with protein kinase A likewise did not reactivate TgTF1. Cells chronically exposed to Ras did, however, yield differentiated clones after treatment with 5-azacytidine. We suggest that Ras induces dedifferentiation in two sequential steps: (1) Ras reduces PKA activity; TgTF1 (or an auxiliary protein) becomes dephosphorylated, and binding to pTg is abolished. (2) The effects of Ras become imprinted by methylation, possibly of the TgTF1 gene.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M Xing BRAF mutation in thyroid cancer Endocr. Relat. Cancer, June 1, 2005; 12(2): 245 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. De Vita, L. Bauer, V. M. C. da Costa, M. De Felice, M. G. Baratta, M. De Menna, and R. Di Lauro Dose-Dependent Inhibition of Thyroid Differentiation by RAS Oncogenes Mol. Endocrinol., January 1, 2005; 19(1): 76 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Medina, M. Rivas, P. Cruz, I. Barroso, J. Regadera, and P. Santisteban RhoA Activation Promotes Transformation and Loss of Thyroid Cell Differentiation Interfering with Thyroid Transcription Factor-1 Activity Mol. Endocrinol., January 1, 2002; 16(1): 33 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kimura, A. Van Keymeulen, J. Golstein, A. Fusco, J. E. Dumont, and P. P. Roger Regulation of Thyroid Cell Proliferation by TSH and Other Factors: A Critical Evaluation of in Vitro Models Endocr. Rev., October 1, 2001; 22(5): 631 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Feliciello, G. Allevato, A. M. Musti, D. De Brasi, A. Gallo, V. E. Avvedimento, and M. E. Gottesman Thyroid Transcription Factor 1 Phosphorylation Is Not Required for Protein Kinase A-dependent Transcription of the Thyroglobulin Promoter Cell Growth Differ., December 1, 2000; 11(12): 649 - 654. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Ohmori, N. Harii, T. Endo, and T. Onaya Tumor Necrosis Factor-{alpha} Regulation of Thyroid Transcription Factor-1 and Pax-8 in Rat Thyroid FRTL-5 Cells Endocrinology, October 1, 1999; 140(10): 4651 - 4658. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. M. Venkataraman, M. Yatin, R. Marcinek, and K. B. Ain Restoration of Iodide Uptake in Dedifferentiated Thyroid Carcinoma: Relationship to Human Na+/I- Symporter Gene Methylation Status J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2449 - 2457. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. H. G. Verheijen, R. M. F. Wolthuis, J. L. Bos, and L. H. K. Defize The Ras/Erk Pathway Induces Primitive Endoderm but Prevents Parietal Endoderm Differentiation of F9 Embryonal Carcinoma Cells J. Biol. Chem., January 15, 1999; 274(3): 1487 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Feliciello, C. S. Rubin, E. V. Avvedimento, and M. E. Gottesman Expression of A Kinase Anchor Protein 121 Is Regulated by Hormones in Thyroid and Testicular Germ Cells J. Biol. Chem., September 4, 1998; 273(36): 23361 - 23366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Velasco, A. Acebron, M. Zannini, J. MartIn-Perez, R. Di Lauro, and P. Santisteban Ha-ras Interference with Thyroid Cell Differentiation Is Associated with a Down-Regulation of Thyroid Transcription Factor-1 Phosphorylation Endocrinology, June 1, 1998; 139(6): 2796 - 2802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ohmori, T. Endo, N. Harii, and T. Onaya A Novel Thyroid Transcription Factor Is Essential for Thyrotropin-Induced Up-Regulation of Na+/I- Symporter Gene Expression Mol. Endocrinol., May 1, 1998; 12(5): 727 - 736. [Abstract] [Full Text]
|
|
|
|
|
|
A. S. Kumar, V. C. Venkatesh, B. C. Planer, S. I. Feinstein, and P. L. Ballard Phorbol Ester Down-regulation of Lung Surfactant Protein B Gene Expression by Cytoplasmic Trapping of Thyroid Transcription Factor-1 and Hepatocyte Nuclear Factor 3 J. Biol. Chem., August 15, 1997; 272(33): 20764 - 20773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Feliciello, P. Giuliano, A. Porcellini, C. Garbi, S. Obici, E. Mele, E. Angotti, D. Grieco, G. Amabile, S. Cassano, et al. The v-Ki-Ras Oncogene Alters cAMP Nuclear Signaling by Regulating the Location and the Expression of cAMP-dependent Protein Kinase IIbeta J. Biol. Chem., October 11, 1996; 271(41): 25350 - 25359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Bradford, K. E. Conrad, P. H. Tran, M. C. Ostrowski, and A. Gutierrez-Hartmann GHF-1/Pit-1 Functions as a Cell-specific Integrator of Ras Signaling by Targeting the Ras Pathway to a Composite Ets-1/GHF-1 Response Element J. Biol. Chem., October 4, 1996; 271(40): 24639 - 24648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Gallo, E Benusiglio, I M Bonapace, A Feliciello, S Cassano, C Garbi, A M Musti, M E Gottesman, and E V Avvedimento v-ras and protein kinase C dedifferentiate thyroid cells by down-regulating nuclear cAMP-dependent protein kinase A. Genes & Dev., September 1, 1992; 6(9): 1621 - 1630. [Abstract] [PDF]
|
|
